Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (GB:0M0F)
LSE:0M0F
Tandem Diabetes Care (0M0F) Share Price & Analysis
1 Followers
0M0F Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.89 - $41.07
Previous Close$31.49
Volume128.00
Average Volume (3M)693.00
Market Cap
$2.05B
Enterprise Value$1.97B
Total Cash (Recent Filing)$498.16M
Total Debt (Recent Filing)$418.21M
Price to Earnings (P/E)N/A
Beta1.13
Next Earnings
May 02, 2024EPS Estimate
-$0.76Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding65,631,041
10 Day Avg. Volume41
30 Day Avg. Volume693
Standard Deviation0.13
R-Squared0.02
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)6.90
Price to Sales (P/S)7.60
Price to Cash Flow (P/CF)-74.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.55
Enterprise Value/Gross Profit4.77
Enterprise Value/Ebitda-12.32
Forecast
1Y Price Target
$33.75Price Target Upside7.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Tandem Diabetes Care News
Bulls Say, Bears Say
Bulls Say
Market Share And Revenue GrowthTNDM's product portfolio and late-stage pipeline position it for solid multiyear revenue growth, an outlook that is not reflected in the stock's depressed valuation.
New Product Launches2024 is positioned to be a year of tremendous opportunity for Tandem with upcoming launches of t:slim X3, Sigi, a better AID System, and a tubeless Mobi pump.
Product Feedback And AdoptionAnalyst upgrades TNDM stock to Buy and raises target price to $37 based on strong Mobi product feedback and potential for rapid adoption.
Bears Say
Financial PerformanceQ4 EBITDA margin of 2% came in light versus the expected 7%, impacted by rebate pricing adjustments in France.
Market CompetitionChallenges such as declining MDT user base, improved competitor user retention, and increasing competition from MDI solutions may pressure the company in the upcoming years.
Product AdoptionTNDM's lack of broad pharmacy access is expected to limit Mobi's adoption in T2D patients.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.83% Insiders
43.28% Mutual Funds
24.90% Other Institutional Investors
30.99% Public Companies and
Individual Investors
0M0F FAQ
What was Tandem Diabetes Care’s price range in the past 12 months?
Tandem Diabetes Care lowest share price was $13.89 and its highest was $41.06 in the past 12 months.
What is Tandem Diabetes Care’s market cap?
Currently, no data Available
When is Tandem Diabetes Care’s upcoming earnings report date?
Tandem Diabetes Care’s upcoming earnings report date is May 02, 2024 which is in 14 days.
How were Tandem Diabetes Care’s earnings last quarter?
Tandem Diabetes Care released its earnings results on Feb 21, 2024. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.27 by -$0.19.
Is Tandem Diabetes Care overvalued?
According to Wall Street analysts Tandem Diabetes Care’s price is currently Undervalued.
Does Tandem Diabetes Care pay dividends?
Tandem Diabetes Care does not currently pay dividends.
What is Tandem Diabetes Care’s EPS estimate?
Tandem Diabetes Care’s EPS estimate is -$0.76.
How many shares outstanding does Tandem Diabetes Care have?
Tandem Diabetes Care has 64,563,480 shares outstanding.
What happened to Tandem Diabetes Care’s price movement after its last earnings report?
Tandem Diabetes Care reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.27. Following the earnings report the stock price went up 15.084%.
Which hedge fund is a major shareholder of Tandem Diabetes Care?
Among the largest hedge funds holding Tandem Diabetes Care’s share is Eminence Capital LLC. It holds Tandem Diabetes Care’s shares valued at 153M.
---
Tandem Diabetes Care Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$33.75 (7.18% Upside)
$33.75 (7.18% Upside)
Blogger Sentiment
Bullish
GB:0M0F Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.55%
12-Months-Change
Fundamentals
Return on Equity
-59.08%
Trailing 12-Months
Asset Growth
-9.51%
Trailing 12-Months
Company Description
Tandem Diabetes Care
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
---
0M0F Company Deck
---
0M0F Earnings Call
Q4 2024
0:00 / 0:00
---
0M0F Revenue Breakdown
74.21% U.S.
25.79% International
---
0M0F Stock 12 Months Forecast
Average Price Target
$33.75
▲(7.18% Upside)
Technical Analysis
Best Analysts Covering 0M0F
1 Year
1 Year Success Rate
21/26 ratings generated profit
1 Year Average Return
+134.67%
reiterated a buy rating 7 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 80.77% of your transactions generating a profit, with an average return of +134.67% per trade.
---